Insider Trading activities of Wave Life Sciences Ltd. (WVE)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Wave Life Sciences Ltd. (WVE) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Wave Life Sciences Ltd. since year 2005. Table 2 shows the detailed insider transactions of Wave Life Sciences Ltd. since 2005. The reporting company's ticker symbol is WVE. The reporting company's CIK number is 1631574.
The total value of stock buying since 2005 is $53,101,556.
The total value of stock sales since 2005 is $26,564,751.
The total value of stock option exercises since 2005 is $1,638,825.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Wave Life Sciences Ltd. (WVE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-07 0 $0 3,058 $82,780 0 $0
2019-03 0 $0 57,000 $2,618,000 50,000 $124,000
2019-02 0 $0 14,632 $539,681 0 $0
2019-01 263,158 $10,000,004 0 $0 0 $0
2018-11 0 $0 15,000 $585,825 0 $0
2018-09 0 $0 44,075 $2,435,700 44,075 $652,400
2018-07 0 $0 24,496 $924,356 24,496 $60,750
2018-06 0 $0 24,496 $1,175,808 24,496 $60,750
2018-05 0 $0 74,496 $3,364,568 74,496 $184,748
2018-02 0 $0 45,930 $2,404,632 41,666 $463,517
2018-01 0 $0 2,000 $80,000 2,000 $4,960
2017-11 423,398 $9,881,552 1,500 $52,500 1,500 $3,720
2017-09 0 $0 20,747 $502,300 0 $0
2017-07 0 $0 7,414 $123,621 0 $0
2017-03 0 $0 433,825 $10,806,580 0 $0
2016-12 0 $0 0 $0 24,000 $59,280
2016-08 0 $0 0 $0 5,000 $12,350
2016-07 0 $0 0 $0 5,000 $12,350
2016-06 0 $0 52,000 $868,400 0 $0
2015-11 2,076,250 $33,220,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Wave Life Sciences Ltd. insiders (WVE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-07-05 Panzara Michael A. (Chief Medical Officer) Sale 3,058 27.07 82,780
2019-03-15 Bolno Paul (President and CEO) Sale 50,000 45.64 2,282,000
2019-03-15 Bolno Paul (President and CEO) Option Ex 50,000 2.48 124,000
2019-03-11 Panzara Michael A. (Franchise Lead, Neurology) Sale 7,000 48.00 336,000
2019-02-19 Regnante Keith (Chief Financial Officer) Sale 1,298 36.84 47,818
2019-02-19 Panzara Michael A. (Franchise Lead, Neurology) Sale 1,837 36.84 67,673
2019-02-19 Bolno Paul (President and CEO) Sale 7,733 36.92 285,525
2019-02-19 Francis Chris (See Remarks) Sale 1,709 36.84 62,959
2019-02-19 Vargeese Chandra (Senior VP, Drug Discovery) Sale 2,055 36.84 75,706
2019-01-24 Kolchinsky Peter Buy 263,158 38.00 10,000,004
2018-11-14 Verdine Gregory L. (Director) Sale 15,000 39.05 585,825
2018-09-25 Francis Chris (See Remarks) Sale 10,543 56.00 590,408
2018-09-25 Francis Chris (See Remarks) Option Ex 10,543 2.48 26,146
2018-09-24 Regnante Keith (Chief Financial Officer) Sale 29,500 55.00 1,622,500
2018-09-24 Regnante Keith (Chief Financial Officer) Option Ex 29,500 20.89 616,255
2018-09-24 Francis Chris (See Remarks) Sale 1,032 56.00 57,792
2018-09-24 Francis Chris (See Remarks) Option Ex 1,032 2.48 2,559
2018-09-24 Vargeese Chandra (Senior VP, Drug Discovery) Sale 3,000 55.00 165,000
2018-09-24 Vargeese Chandra (Senior VP, Drug Discovery) Option Ex 3,000 2.48 7,440
2018-07-09 Francis Chris (See Remarks) Sale 24,496 37.73 924,356
2018-07-09 Francis Chris (See Remarks) Option Ex 24,496 2.48 60,750
2018-06-01 Francis Chris (See Remarks) Sale 24,496 48.00 1,175,808
2018-06-01 Francis Chris (See Remarks) Option Ex 24,496 2.48 60,750
2018-05-30 Bolno Paul (President and CEO) Sale 20,250 45.00 911,250
2018-05-30 Bolno Paul (President and CEO) Option Ex 20,250 2.48 50,220
2018-05-30 Francis Chris (See Remarks) Sale 24,496 45.50 1,114,568
2018-05-30 Francis Chris (See Remarks) Option Ex 24,496 2.48 60,750
2018-05-29 Bolno Paul (President and CEO) Sale 3,145 45.00 141,525
2018-05-29 Bolno Paul (President and CEO) Option Ex 3,145 2.48 7,799
2018-05-25 Bolno Paul (President and CEO) Sale 8,316 45.00 374,220
2018-05-25 Bolno Paul (President and CEO) Option Ex 8,316 2.48 20,623
2018-05-02 Bolno Paul (President and CEO) Sale 18,289 45.00 823,005
2018-05-02 Bolno Paul (President and CEO) Option Ex 18,289 2.48 45,356
2018-02-20 Francis Chris (See Remarks) Sale 11,504 55.95 643,648
2018-02-20 Francis Chris (See Remarks) Option Ex 11,504 2.48 28,529
2018-02-16 Regnante Keith (Chief Financial Officer) Sale 316 51.85 16,384
2018-02-16 Panzara Michael A. (Franchise Lead, Neurology) Sale 511 52.10 26,623
2018-02-16 Bolno Paul (President and CEO) Sale 2,714 51.31 139,268
2018-02-16 Francis Chris (See Remarks) Sale 10,135 53.40 541,209
2018-02-16 Francis Chris (See Remarks) Option Ex 9,412 2.48 23,341
2018-02-15 Panzara Michael A. (Franchise Lead, Neurology) Sale 18,750 50.00 937,500
2018-02-15 Panzara Michael A. (Franchise Lead, Neurology) Option Ex 18,750 21.69 406,687
2018-02-15 Vargeese Chandra (See Remarks) Sale 2,000 50.00 100,000
2018-02-15 Vargeese Chandra (See Remarks) Option Ex 2,000 2.48 4,960
2018-01-23 Vargeese Chandra (See Remarks) Sale 2,000 40.00 80,000
2018-01-23 Vargeese Chandra (See Remarks) Option Ex 2,000 2.48 4,960
2017-11-22 Vargeese Chandra (See Remarks) Sale 1,500 35.00 52,500
2017-11-22 Vargeese Chandra (See Remarks) Option Ex 1,500 2.48 3,720
2017-11-14 Kolchinsky Peter Buy 23,398 24.00 561,552
2017-11-13 Kolchinsky Peter Buy 400,000 23.30 9,320,000
2017-09-18 Kagoshima Shinsangyo Sousei Investment Limited Partnership (10% Owner) Sale 6,362 24.19 153,896
2017-09-15 Kagoshima Shinsangyo Sousei Investment Limited Partnership (10% Owner) Sale 14,385 24.22 348,404
2017-07-12 Panzara Michael A. (Franchise Lead, Neurology) Sale 7,414 16.67 123,621
2017-03-29 Kagoshima Shinsangyo Sousei Investment Limited Partnership (10% Owner) Sale 433,825 24.91 10,806,580
2016-12-07 Guerciolini Roberto (See Remarks) Option Ex 24,000 2.47 59,280
2016-08-19 Guerciolini Roberto (See Remarks) Option Ex 5,000 2.47 12,350
2016-07-28 Guerciolini Roberto (See Remarks) Option Ex 5,000 2.47 12,350
2016-06-15 Verdine Gregory L. (Director) Sale 52,000 16.70 868,400
2015-11-16 Shin Nippon Biomedical Laboratories, Ltd. (10% Owner) Buy 125,000 16.00 2,000,000
2015-11-16 Kagoshima Shinsangyo Sousei Investment Limited Partnership (10% Owner) Buy 76,250 16.00 1,220,000
2015-11-16 Ra Capital Healthcare Fund Lp Buy 1,875,000 16.00 30,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of WVE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Wave Life Sciences Ltd. (symbol WVE, CIK number 1631574) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month